Cellectis Nom Eo 05【ALCLS】銘柄情報

Cellectis Nom Eo 05 (ALCLS) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

2.764

( 0.29% )

買値

2.73

売値

2.78

出来高

197,672

2.71 日の範囲 2.87

1.234 52 週間の範囲 4.75

時価総額

200.672M

前日終値

2.756

始値

2.788

時刻

147

2.764

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

303,468 €

発行済株式数

72,601,869

配当利回り

PER

-4.5

1 株当たり利益 (EPS)

-0.67

歳入

75.11M

純利益

-67.23M

Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is ... Cellectis S.A., a clinical stage biotechnological company, develops products based on gene-editing with a portfolio of allogeneic chimeric antigen receptor T-cells product candidates in the field of immuno-oncology and gene therapy product candidates in other therapeutic indications. The company is developing BALLI-01, to evaluate the safety, expansion, persistence, and clinical activities of lasme-cel in patients with r/r ALL; NatHaLi-01, designed to evaluate the safety, expansion, persistence, and clinical activity of eti-cel in patients with relapsed or refractory B-Cell Non-Hodgkin's Lymphoma (B-NHL). It also develops ALPHA3, targets Large B-Cell Lymphoma (LBCL); TRAVERSE, for the treatment of patients with advanced or metastatic clear cell renal cell carcinoma (RCC). In addition, the company Melanoma, for treatment of unresectable or metastatic melanoma. Cellectis S.A. was founded in 1999 and is headquartered in Paris, France. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.cellectis.com

本社

Paris, France

設立

1999

Cellectis Nom Eo 05 is listed in the Healthcare sector of the ユーロネクスト with ticker ALCLS. The last closing price for Cellectis Nom Eo 05 was 2.76 €. Over the last year, Cellectis Nom Eo 05 shares have traded in a share price range of 1.234 € to 4.75 €.

Cellectis Nom Eo 05 currently has 72,601,869 shares in issue. The market capitalisation of Cellectis Nom Eo 05 is 200.67 € million. Cellectis Nom Eo 05 has a price to earnings ratio (PE ratio) of -4.50.

Cellectis présente les résultats finaux de phase 1 pour lasmé-cel et des résultats préliminaires pour éti-cel au congrès de l’EHA 2026

Cellectis présente les résultats finaux de phase 1 pour lasmé-cel et des résultats préliminaires pour éti-cel au congrès de l’EHA 2026 NEW YORK...

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress NEW YORK, June 11, 2026 (GLOBE...

Cellectis Presents Final Phase 1 Results of Lasme-cel and Preliminary Results on Eti-cel at EHA 2026 Congress

NEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ:...

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL NEW YORK...

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de...

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

NEW YORK, June 09, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS - NASDAQ:...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.144	5.49618320611	2.62	3.06	2.512	451534	2.6979509	DE
4	-0.806	-22.5770308123	3.57	3.73	2.512	340881	2.97907331	DE
12	-0.216	-7.24832214765	2.98	4.14	2.512	357141	3.27486612	DE
26	-1.736	-38.5777777778	4.5	4.53	2.512	323058	3.43580713	DE
52	1.482	115.600624025	1.282	4.75	1.234	375935	3.28713831	DE
156	0.814	41.7435897436	1.95	4.75	0.888	198465	2.75952805	DE
260	-9.956	-78.2704402516	12.72	13.81	0.888	183363	3.35171473	DE